Bausch + Lomb Corporation Common Shares (NY:BLCO)

17.14 +0.04 (+0.20%)

Delayed Quote Updated: 11:23 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bausch + Lomb Corporation Common Shares

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Bausch + Lomb Bolsters Pipeline with Acquisition of Whitecap Biosciences

January 13, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Launches enVista Aspire™ Intermediate Optimized Monofocal and Toric Intraocular Lenses in the European Union

January 13, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb and Glaucoma Research Foundation Launch Second Annual “Faces of Glaucoma” Campaign and Fundraising Challenge

January 07, 2025

From Bausch + Lomb Corporation

Via Business Wire

Why Bausch + Lomb Rallied Today ↗

September 16, 2024

The highly indebted healthcare stock rose on rumors it may be selling itself.

Via The Motley Fool

Bausch + Lomb to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

January 02, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Responds to Rumors of a Potential Sale

December 12, 2024

From Bausch + Lomb Corporation

Via Business Wire

Macy's, Dave & Buster's, Bausch + Lomb And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

December 11, 2024

Via Benzinga

Bausch + Lomb Acquires Elios Vision, Significantly Enhances Glaucoma Treatment Capabilities

December 11, 2024

From Bausch + Lomb Corporation

Via Business Wire

Deal Dispatch: Ubisoft In Buyout Talks, Dental Supplier Explores Sale, Beloved Drive-Through Goes Bankrupt ↗

December 07, 2024

Dental supply maker Patterson Companies Inc announced Thursday that it is exploring strategic options, including a sale or merger, to boost shareholder value.

Via Benzinga

Topics Supply Chain

Bausch + Lomb Reports More Than 94 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling Programs

November 14, 2024

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces Third-Quarter 2024 Results

October 30, 2024

From Bausch + Lomb Corporation

Via Business Wire

Deal Dispatch: UFC, WWE Parent TKO Takes On Bull Riding; Endeavor Looks To Sell Tennis; Another Car Company Goes Bankrupt ↗

October 26, 2024

IMG tennis assets are on the auction block. The announcement came after TKO inked a deal with Endeavor for Professional Bull Riders.

Via Benzinga

Deal Dispatch: Altus Power, Motorsport Games Explore Options, True Value Goes Bankrupt, M&A Activity Lags ↗

October 21, 2024

S&P Global's Joe Mantone puts the latest M&A data in perspective and how deal pros might react post-Election Day.

Via Benzinga

Topics Bankruptcy Stocks

This Advance Auto Parts Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday ↗

October 15, 2024

Via Benzinga

Why Bausch + Lomb Stock Soared by Over 7% on Monday ↗

October 14, 2024

It was quite a busy and eventful day for the company.

Via The Motley Fool

NVIDIA, Trump Media & Technology, Bausch + Lomb, Sirius XM And Other Big Stocks Moving Higher On Monday ↗

October 14, 2024

Via Benzinga

Topics Government

Bausch + Lomb Sale Process Gains Momentum As TPG And Blackstone Join Forces ↗

October 14, 2024

Private equity giants TPG and Blackstone are pursuing a potential $14 billion buyout of Bausch + Lomb.

Via Benzinga

Bausch + Lomb Receives FDA Approval for enVista® Envy™ Full Range of Vision Intraocular Lens

October 14, 2024

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Will Release Third-Quarter 2024 Financial Results on October 30

October 09, 2024

From Bausch + Lomb Corporation

Via Business Wire

Nike Reports Weak Sales, Joins Lamb Weston And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

October 02, 2024

Via Benzinga

Bausch + Lomb Launches Opal™ Digital Marketplace in the United States

October 01, 2024

From Bausch + Lomb Corporation

Via Business Wire

Bausch Health: A Buyout Bid Could Be the Ticket to Unlock Value

September 25, 2024

The potential sale of Bausch + Lomb, Bausch Health's eye care business, could result in a financial gain for the company by reducing its debt burden.

Via MarketBeat

Bausch & Lomb And Edgewise Therapeutics Are Among Top 7 Mid Cap Stock Gainers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio? ↗

September 22, 2024

Federal Reserve's rate cut boosted tech, construction, industrial, machinery, and financial sectors. Top-performing mid-cap stocks last week.

Via Benzinga

Topics Economy

Applied Therapeutics, PowerFleet, VF Corp, Victoria's Secret And Other Big Stocks Moving Higher On Wednesday ↗

September 18, 2024

Via Benzinga

Contact Lens Supplier Bausch + Lomb Eyes Sale Amid Separation Challenges As Parent Bausch Health Faces Debt Issues ↗

September 16, 2024

Bausch + Lomb is exploring a sale as its parent company, Bausch Health, faces significant debt and creditors' opposition to a spin-off.

Via Benzinga

Topics Supply Chain

Bausch Reportedly Explores A Sale; Could Alcon, J&J Or AbbVie Buy It? ↗

September 16, 2024

Bausch + Lomb is reportedly considering a sale. But its potential acquirers could come up against antitrust concerns.

Via Investor's Business Daily

Alcoa, Lattice Semiconductor, Stratasys And Other Big Stocks Moving Higher On Monday ↗

September 16, 2024

Via Benzinga

Tech Stocks On Track For Best Session In 5 Months Ahead Of Fed Meeting; Small Caps Target Highest Close Since January 2022: What's Driving Markets Wednesday? ↗

July 31, 2024

Tech stocks soared to their best session in five months on Wednesday, ahead of the highly anticipated Federal Open Market Committee (FOMC) meeting.

Via Benzinga

Topics Economy

Bausch + Lomb Announces Second-Quarter 2024 Results

July 31, 2024

From Bausch + Lomb Corporation

Via Business Wire

Wall Street Remains On Track For AMD-Led Rebound Ahead Of Fed Decision, Meta Earnings: Analyst Says 'The Bull Tends To Remain' Despite Near-Time Volatility ↗

July 31, 2024

Tech optimism is likely to abound on Wall Street as AI-levered stocks are feeding off the strength generated by Advanced Micro Devices, Inc.‘s (NASDAQ:AMD)

Via Benzinga

Topics Economy

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.